Breast-Conserving Therapy for Breast Cancer: Targets for Investigation to Improve Results
暂无分享,去创建一个
[1] M. West,et al. Gene expression predictors of breast cancer outcomes , 2003, The Lancet.
[2] Julia White,et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. , 2003, International journal of radiation oncology, biology, physics.
[3] John Wong,et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. , 2000 .
[4] L. Jacobs,et al. Positive Margins: The Challenge Continues for Breast Surgeons , 2008, Annals of Surgical Oncology.
[5] J E Mortimer,et al. Factors influencing cosmetic results after conservation therapy for breast cancer. , 1995, International journal of radiation oncology, biology, physics.
[6] M Metaxas,et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] Mike Clarke,et al. Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[8] G. Q. della Rovere,et al. Ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis? , 2002, The Lancet. Oncology.
[9] R. A’Hern,et al. The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants. , 2006, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[10] L. Esserman,et al. Magnetic Resonance Imaging in Patients Diagnosed With Ductal Carcinoma-In-Situ: Value in the Diagnosis of Residual Disease, Occult Invasion, and Multicentricity , 2003, Annals of Surgical Oncology.
[11] Renee F Wilson,et al. Systematic Review: Gene Expression Profiling Assays in Early-Stage Breast Cancer , 2008, Annals of Internal Medicine.
[12] Andreas Makris,et al. Early breast cancer , 2009, The Lancet.
[13] B. E. F. Isher,et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .
[14] M Ciocca,et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. , 2001, European journal of cancer.
[15] A. Wilson,et al. Cosmesis and satisfaction after breast‐conserving surgery correlates with the percentage of breast volume excised , 2003, The British journal of surgery.
[16] R Sarin,et al. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[17] Zoya I. Volynskaya,et al. In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopy. , 2006, Cancer research.
[18] A. Munshi,et al. Factors influencing cosmetic outcome in breast conservation. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).
[19] S. Schnell,et al. A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies , 2006, Theoretical Biology and Medical Modelling.
[20] H. Kuerer,et al. Three‐year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI) , 2008, Cancer.
[21] Kazunori Taguchi,et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. , 2004, Journal of the American College of Surgeons.
[22] Umberto Veronesi,et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.
[23] K. Oberg,et al. Aesthetic outcomes in patients undergoing breast conservation therapy for the treatment of localized breast cancer. , 2004, Plastic and reconstructive surgery.
[24] Yasuo Miyoshi,et al. Basal-like subtype and BRCA1 dysfunction in breast cancers , 2008, International Journal of Clinical Oncology.
[25] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[26] R. Drezek,et al. Silica-gold nanoshells as potential intraoperative molecular probes for HER2-overexpression in ex vivo breast tissue using near-infrared reflectance confocal microscopy , 2010, Breast Cancer Research and Treatment.
[27] R. Pleijhuis,et al. Obtaining Adequate Surgical Margins in Breast-Conserving Therapy for Patients with Early-Stage Breast Cancer: Current Modalities and Future Directions , 2009, Annals of Surgical Oncology.
[28] B. Cho,et al. Factors Associated with Negative Margins of Lumpectomy Specimen: Potential Use in Selecting Patients for Intraoperative Radiotherapy , 2008, Annals of surgical oncology.
[29] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.